- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Bullion Gold Resources Corp (2): Bullion Gold acquisition of Abitibi mining claims | 1 | Stockwatch | ||
| 27.01. | Bullion Gold Resources Corp (2): Bullion Gold takes 100% ownership of Terragold | 2 | Stockwatch | ||
| 26.01. | Bullion Gold Resources Corporation: Bullion Gold Acquires 100% of the Terragold Project and Consolidates a Strategic Gold Asset | 246 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the signing of an amendment to the original... ► Artikel lesen | |
| 09.01. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 2 | Stockwatch | ||
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 06.01. | Bullion Gold Resources Corporation: High-Grade Gold up to 12.2 g/t Intersected in Multiple Structures at Bousquet | 489 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 6, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") is pleased to announce further assay results for the Bousquet... ► Artikel lesen | |
| 24.12.25 | Bullion Gold Resources Corp (2): Bullion Gold closes $300,000 private placement | 2 | Stockwatch | ||
| 23.12.25 | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 366 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 23, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 02.12.25 | Bullion Gold Resources Corporation: Bullion Gold Presents the Historical Overview of Its Terragold Gold Project | 397 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 2, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") will soon file an ATI permit application for a stripping and drilling... ► Artikel lesen | |
| 26.11.25 | Bullion Gold Resources Corporation: Bullion Gold Acquires the Transterre, Transterre-Ouest, and Candore Gold Projects (Forming the Terragold Project) | 449 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 26, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") is pleased to announce the signing of an acquisition agreement... ► Artikel lesen | |
| 14.11.25 | Bullion Gold Resources Corp (2): Bullion begins survey at Langlade, appoints director | 1 | Stockwatch | ||
| 13.11.25 | Bullion Gold Resources Corporation: Bullion Gold Begins Geochemical Survey of Base Till on Langlade and Appoints a New Director to Its Board | 435 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 13, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is proud to announce the launch of an intensive follow-up program... ► Artikel lesen | |
| 29.10.25 | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
| 28.10.25 | Bullion Gold Resources Corporation: 1.7km Gold System Emerging at Decoeur | 413 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 28, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to further assay results have been received for the Decoeur Prospect... ► Artikel lesen | |
| 22.10.25 | Bullion Gold Resources Corp (2): Bullion hires ITG as market-maker, arranges financing | 1 | Stockwatch | ||
| 21.10.25 | Bullion Gold Resources Corporation: Bullion Gold Engages Independent Trading Group as Market Maker, Announces Private Placement. | 1.079 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 21, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") announces that, subject to regulatory approval, it has engaged the services... ► Artikel lesen | |
| 10.10.25 | Bullion Gold Resources Corp (2): Bullion Gold identifies Au grains at Cadillac-Extension | 1 | Stockwatch | ||
| 09.10.25 | Bullion Gold Resources Corporation: Bullion Gold Identifies Coarse, Irregular Gold Grains North of Langlade VMS Prospect (Cadillac-Extension Project), Launches Expanded Basal Till Sampling Program. | 303 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 9, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to announce encouraging preliminary results from a test basal... ► Artikel lesen | |
| 04.10.25 | Bullion Gold Resources Corp (2): Bullion Gold Resources private placement | 1 | Stockwatch | ||
| 02.10.25 | Bullion Gold Resources Corp (2): Bullion Gold's Canico samples return up to 2.16 g/t Au | 1 | Stockwatch | ||
| 02.10.25 | Bullion Gold Resources Corporation: Bullion Gold Confirms a Promising New Polymetallic Showing at Bodo and Identifies a Potential IOCG/SKARN-type Target | 456 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 2, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the confirmation of the polymetallic character... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES | 319,57 | +4,56 % | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| QIAGEN | 43,170 | -0,70 % | Diagnostikkonzern Qiagen überrascht im Schlussquartal - Weiteres Wachstum 2026 | VENLO/HILDEN (dpa-AFX) - Qiagen hat 2025 von einer anziehenden Nachfrage nach seinen Kernprodukten profitiert. Dabei lief das Schlussquartal besser als vom Labordienstleister und Diagnostikkonzern... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 72,90 | +0,11 % | Avidity Biosciences, Inc. - 8-K, Current Report | ||
| TARSUS PHARMACEUTICALS | 64,62 | +4,24 % | Tarsus Pharmaceuticals, Inc: Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements | Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-year Weekly multi-patient prescribers grew approximately 30% in the third quarter underscoring... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 14,990 | +8,23 % | H.C. Wainwright reiterates Buy rating on Summit Therapeutics stock | ||
| ERASCA | 12,290 | +3,45 % | Erasca, Inc.: Erasca Announces Pricing of Upsized Public Offering of Common Stock | SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 3,960 | +11,24 % | Recursion Pharmaceuticals, Inc.: Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks | REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12)After 12 weeks... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 62,19 | +0,10 % | Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns | ||
| IMMUNOVANT | 27,040 | +12,39 % | Immunovant Inc.: Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025 | IMVT-1402 potentially registrational trial in difficult-to-treat rheumatoid arthritis (D2T RA) fully enrolled, with topline data expected in the second half of calendar year 2026; topline data from... ► Artikel lesen | |
| STRUCTURE THERAPEUTICS | 74,96 | +2,39 % | Structure Therapeutics Inc.: Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity | SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for... ► Artikel lesen | |
| MINERALYS THERAPEUTICS | 29,770 | +5,53 % | Mineralys Therapeutics, Inc.: Mineralys Therapeutics' Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) "Research of the Year" Roundup | - Launch-HTN, the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension, was one of nine studies selected as most impactful... ► Artikel lesen | |
| LIMINATUS PHARMA | 1,840 | -10,24 % | Liminatus Pharma, Inc. - 8-K, Current Report | ||
| DAY ONE BIOPHARMACEUTICALS | 11,410 | +8,87 % | Day One Biopharmaceuticals, Inc.: Day One Announces Preliminary 2025 OJEMDA Net Product Revenue And Provides 2026 Net Product Revenue Guidance | Preliminary 2025 net product revenue of $155.4 million, representing 172% year-over-year growth; OJEMDA 2026 U.S. net product revenue projected to be $225 - $250 million Company to present on corporate... ► Artikel lesen | |
| AMYLYX PHARMACEUTICALS | 13,980 | +7,62 % | Gubra A/S: Amylyx Pharmaceuticals Announces Nomination of AMX0318 as a Novel, Long-Acting GLP-1 Receptor Antagonist Development Candidate, Identified in Collaboration with Gubra | AMX0318 selected as development candidate after meeting key criteria, demonstrating a robust chemical stability profile, strong in vitro potency, evidence of in vivo efficacy and tolerability, high... ► Artikel lesen | |
| OLEMA PHARMACEUTICALS | 25,360 | +1,40 % | Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Das Unternehmen BULLION GOLD RESOURCES CORPORATION kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.